Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005
Abstract
A recent systematic review concluded that cannabis use increases risk of psychotic outcomes independently of confounding and transient intoxication effects. Furthermore, a model of the association between cannabis use and schizophrenia indicated that the incidence and prevalence of schizophrenia would increase from 1990 onwards. The model is based on three factors: a) increased relative risk of psychotic outcomes for frequent cannabis users compared to those who have never used cannabis between 1.8 and 3.1, b) a substantial rise in UK cannabis use from the mid-1970s and c) elevated risk of 20 years from first use of cannabis. This paper investigates whether this has occurred in the UK by examining trends in the annual prevalence and incidence of schizophrenia and psychoses, as measured by diagnosed cases from 1996 to 2005. Retrospective analysis of the General Practice Research Database (GPRD) was conducted for 183 practices in England, Wales, Scotland and Northern Ireland. The study cohort comprised almost 600,000 patients each year, representing approximately 2.3% of the UK population aged 16 to 44. Between 1996 and 2005 the incidence and prevalence of schizophrenia and psychoses were either stable or declining. Explanations other than a genuine stability or decline were considered, but appeared less plausible. In conclusion, this study did not find any evidence of increasing schizophrenia or psychoses in the general population from 1996 to 2005.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies have found that incidence of psychotic outcomes has increased in recent decades, while others have found no change, or a decrease.
“Some studies have found that incidence of psychotic outcomes has increased in recent decades (58,59), while others have found no change, or a decrease (60,61).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [61]
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · see citing works
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224 · see citing works
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 1,321 · see citing works
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 909 · see citing works
Psychiatric morbidity among adults living in private households, 2000
Singleton, N., Bumpstead, R., O'Brien, M. S., Lee, A., & Meltzer, H. (2003) · International Review of Psychiatry · doi:10.1080/0954026021000045967 · Cited by 896 · see citing works
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839 · see citing works
Use of the UK General Practice Research Database for pharmacoepidemiology
Rodríguez, L. A. G., & Perez‐Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 560 · see citing works
Jané‐Llopis, E., & MATYTSINA, I. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944461 · Cited by 496 · see citing works
Effects of cannabis use on outcomes of psychotic disorders: systematic review
Zammit, S., Moore, T. H., Lingford-Hughes, A. R., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046375 · Cited by 272 · see citing works
Jick, H., Terris, B. Z., Derby, L. E., & Jick, S. S. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010607 · Cited by 265 · see citing works
Reasons for increased substance use in psychosis
Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249 · see citing works
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212 · see citing works
Accuracy of diagnosis of psychosis on general practice computer system.
Nazareth, I., King, M., Haines, A., Rangel, L., & Myers, S. (1993) · BMJ · doi:10.1136/bmj.307.6895.32 · Cited by 196 · see citing works
Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study
Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.014308 · Cited by 166 · see citing works
Drug Misuse Declared: Findings from the 2008/09: British Crime Survey: England and Wales
Hoare, J. (2009) · PsycEXTRA Dataset · doi:10.1037/e586982012-001 · Cited by 161 · see citing works
Rey, J. M., & Tennant, C. C. (2002) · BMJ · doi:10.1136/bmj.325.7374.1183 · Cited by 127 · see citing works
Hickman, M., Vickerman, P. T., Macleod, J., Kirkbride, J. B., & Jones, P. B. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01710.x · Cited by 97 · see citing works
Frisher, M., Crome, I., Macleod, J., Millson, D. S., & Croft, P. R. (2005) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2004.030833 · Cited by 76 · see citing works
Self-citationOutcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort
Lauronen, E., Miettunen, J., Veijola, J. M., Karhu, M., Jones, P. B., & Isohanni, M. K. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.07.001 · Cited by 62 · see citing works
Kuntsche, E. N. (2004) · European Addiction Research · doi:10.1159/000077700 · Cited by 57 · see citing works
Changing incidence of psychotic disorders among the young in Zurich
Ajdacic‐Gross, V., Lauber, C., Warnke, I., Haker, H., Murray, R. M., & Wulf Rössler, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.001 · Cited by 47 · see citing works
Social outcome in schizophrenia: a 13-year follow-up
Munk‐Jørgensen, P., & Mortensen, P. B. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788758 · Cited by 36 · see citing works
Does cannabis use cause schizophrenia?
Macleod, J., Smith, G. D., & Hickman, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68468-7 · Cited by 26 · see citing works
Cowdell, C. (1858) · BMJ · doi:10.1136/bmj.s4-1.99.967 · Cited by 20 · see citing works
Does Cannabis Cause Schizophrenia
Iversen, L. L. (2007) · Journal watch · doi:10.1056/jn200711270000005 · Cited by 5 · see citing works
The primary care of patients with schizophrenia
Burns, T., Kendrick, T., & Cohen, A. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)88821-4 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379 · see citing works
Simeone, J. C., Ward, A. J., Rotella, P., Collins, J., & Windisch, R. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0578-7 · Cited by 327 · see citing works
Recording of Severe Mental Illness in United Kingdom Primary Care, 2000–2010
Hardoon, S., Hayes, J. F., Blackburn, R., Petersen, I., Walters, K., Nazareth, I., & Osborn, D. P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082365 · Cited by 90 · see citing works
- Authors
- Frisher, M., Crome, I., Martino, O., & Croft, P.
- Affiliations
- Keele University (GB)
- Harplands Hospital (GB)
- Corresponding author
- Frisher, Martin
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 113
- Issue
- 2-3
- Pages
- 123-128
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2111803651
- Cited by
- 70
- References
- 26
- Citations by year
- 2023: 16 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 8 · 2012: 4
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- cannabis use, schizophrenia
- MeSH terms
- Adolescent, Adult, Marijuana Abuse, Female, United Kingdom, Humans, Male, Psychotic Disorders, Retrospective Studies, Risk Factors, Schizophrenia, Incidence, Prevalence, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review